Previous close | 3.5000 |
Open | 4.0000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 41.00 |
Expiry date | 2024-06-21 |
Day's range | 3.5000 - 4.1000 |
Contract range | N/A |
Volume | |
Open interest | 74 |
PRINCETON, N.J., May 07, 2024--Bristol Myers Squibb to Participate in Upcoming Investor Conferences
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line....